Integra Lifesciences HLD (iart 0.5 08/15/25)
13F holders, Q2 2025 (June 30)2holders +1
1new positions
0sold out
$0.99avg. 13F price*
At the end of Q2 2025, 2 institutions reported holding Integra Lifesciences HLD (iart 0.5 08/15/25) in their 13F filings, up 1 from Q1 2025. 1 opened new positions and 0 sold out. The largest holders were Truist Financial Corp. ($7.2M) and BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($3.0M).
- Company
- Integra Lifesciences HLD (iart 0.5 08/15/25)
- CUSIP
- 457985AM1
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $7.2M |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 7,295,000 shares bought, net +7,295,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Truist Financial Corp. | 0.01% | New | 7,295,000 | $7.2M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | No change | 3,000,000 | $3.0M |
"% of holder's portfolio" is INTEGRA LIFESCIENCES HLD (IART 0.5 08/15/25)'s weight in each manager's 13F, not the share of Integra Lifesciences HLD (iart 0.5 08/15/25) the manager owns.